F

A

FABI , A.

Last name: FABI

First name: A.

2024 (v1)

Publication

Metadata-only

Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial

Poggio, F. Blondeaux, E. Tagliamento, M.

Background: The phase III GIM2 trial showed improved disease-free survival (DFS) and overall survival (OS) with adjuvant dose-dense (DD) as compared with standard-interval (SI) chemotherapy in women with node-positive early-stage breast cancer (BC). This exploratory analysis aimed to investigate the benefit of different schedules according to...

Uploaded on: August 15, 2024